Annis Gardner Whiting Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-328
Closed -$14.1K – 626
2026
Q1
$14.1K Sell
328
-122
-27% -$5.25K ﹤0.01% 812
2025
Q4
$19.7K Hold
450
– – ﹤0.01% 656
2025
Q3
$18.6K Buy
450
+71
+19% +$2.85K ﹤0.01% 617
2025
Q2
$16.7K Sell
379
-136
-26% -$5.44K 0.01% 596
2025
Q1
$19K Hold
515
– – 0.01% 462
2024
Q4
$17.1K Buy
+515
New +$16.7K ﹤0.01% 464

Other funds holding EXEL

Annis Gardner Whiting Capital Advisors's EXEL Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 328 shares — an estimated $14.1K sold.

Annis Gardner Whiting Capital Advisors first reported a position in EXEL in Q4 2024 and held it in 6 quarters. The position peaked at $19.7K in Q4 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 328 Exelixis shares in Q2 2026, an estimated $14.1K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Exelixis in Q4 2024 and held it in 6 quarters.
  • Annis Gardner Whiting Capital Advisors's Exelixis position peaked at $19.7K in Q4 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.